Sean Ellis - Jan 18, 2022 Form 4/A - Amendment Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Stock symbol
ENTX
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/25/2022, 05:21 PM
Date Of Original Report
Jan 19, 2022
Previous filing
Jan 14, 2022
Next filing
Jul 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 17.2K Jan 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 amendment is being filed to correct the original Form 4 filed on January 19, 2022. The original Form 4 inadvertently omitted 7,200 ordinary shares held directly by the Reporting Person.